Literature DB >> 21501256

Shifting topographic activation and 5-HT1A receptor-mediated inhibition of dorsal raphe serotonin neurons produced by nicotine exposure and withdrawal.

Robin Sperling1, Kathryn G Commons.   

Abstract

Nicotine activates serotonin [5-hydroxytryptamine (5-HT)] neurons innervating the forebrain, and this is thought to reduce anxiety. Nicotine withdrawal has also been associated with an activation of 5-HT neurotransmission, although withdrawal increases anxiety. In each case, 5-HT1A receptors have been implicated in the response. To determine whether there are different subgroups of 5-HT cells activated during nicotine administration and withdrawal, we mapped the appearance of Fos, a marker of neuronal activation, in 5-HT cells of the dorsal raphe nucleus (DR) and median raphe nucleus (MR). To understand the role of 5-HT1A receptor feedback inhibitory pathways in 5-HT cell activity during these conditions, we administered a selective 5-HT1A receptor antagonist and measured novel disinhibited Fos expression within 5-HT cells. Using these approaches, we found evidence that acute nicotine exposure activates 5-HT neurons rostrally and in the lateral wings of the DR, whereas there is 5-HT1A receptor-dependent inhibition of cells located ventrally at both the rostral level and mid-level. Previous chronic nicotine exposure did not modify the pattern of activation produced by acute nicotine exposure, but increased 5-HT1A receptor-dependent inhibition of 5-HT cells in the caudal DR. This pattern was nearly reversed during nicotine withdrawal, when there was evidence for caudal activation and mid-level and rostral 5-HT1A receptor-dependent inhibition. These results suggest that the distinct behavioral states produced by nicotine exposure and withdrawal correlate with reciprocal rostral-caudal patterns of activation and 5-HT1A receptor-mediated inhibition of DR 5-HT neurons. The complementary patterns of activation and inhibition suggest that 5-HT1A receptors may help to shape distinct topographic patterns of activation within the DR.
© 2011 The Authors. European Journal of Neuroscience © 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501256      PMCID: PMC3095684          DOI: 10.1111/j.1460-9568.2011.07677.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  40 in total

1.  Morphological features and electrophysiological properties of serotonergic and non-serotonergic projection neurons in the dorsal raphe nucleus. An intracellular recording and labeling study in rat brain slices.

Authors:  Y Q Li; H Li; T Kaneko; N Mizuno
Journal:  Brain Res       Date:  2001-05-04       Impact factor: 3.252

2.  Effects of nicotine on alcohol intake in a rat model of depression.

Authors:  Dolores Martínez-González; Oscar Prospéro-García; Stefan Mihailescu; René Drucker-Colín
Journal:  Pharmacol Biochem Behav       Date:  2002-05       Impact factor: 3.533

3.  5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning.

Authors:  E Carboni; E Acquas; P Leone; L Perezzani; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1988-06-22       Impact factor: 4.432

4.  The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

Authors:  K Rasmussen; D O Calligaro; J F Czachura; L J Dreshfield-Ahmad; D C Evans; S K Hemrick-Luecke; M J Kallman; W T Kendrick; J D Leander; D L Nelson; C D Overshiner; D B Wainscott; M C Wolff; D T Wong; T A Branchek; J M Zgombick; Y C Xu
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

5.  Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat.

Authors:  D van der Kooy; T Hattori
Journal:  Brain Res       Date:  1980-03-17       Impact factor: 3.252

6.  The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.

Authors:  S Cheeta; E E Irvine; P J Kenny; S E File
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

7.  Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.

Authors:  A A Harrison; Y T Liem; A Markou
Journal:  Neuropsychopharmacology       Date:  2001-07       Impact factor: 7.853

Review 8.  Nicotine dependence: studies with a laboratory model.

Authors:  D H Malin
Journal:  Pharmacol Biochem Behav       Date:  2001-12       Impact factor: 3.533

9.  Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function.

Authors:  S Singer; S Rossi; S Verzosa; A Hashim; R Lonow; T Cooper; H Sershen; A Lajtha
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

10.  Mechanisms of nicotine actions on dorsal raphe serotoninergic neurons.

Authors:  Stefan Mihailescu; Rubén Guzmán-Marín; María del Carmen Frías Domínguez; René Drucker-Colín
Journal:  Eur J Pharmacol       Date:  2002-09-27       Impact factor: 4.432

View more
  16 in total

1.  Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors.

Authors:  Alvaro L Garcia-Garcia; Qingyuan Meng; Sarah Canetta; Alain M Gardier; Bruno P Guiard; Christoph Kellendonk; Alex Dranovsky; E David Leonardo
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

2.  Medial habenula output circuit mediated by α5 nicotinic receptor-expressing GABAergic neurons in the interpeduncular nucleus.

Authors:  Yun-Wei A Hsu; Lynne Tempest; Lely A Quina; Aguan D Wei; Hongkui Zeng; Eric E Turner
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

3.  Enhanced 5-HT1A receptor-dependent feedback control over dorsal raphe serotonin neurons in the SERT knockout mouse.

Authors:  Mariano Soiza-Reilly; Nathalie M Goodfellow; Evelyn K Lambe; Kathryn G Commons
Journal:  Neuropharmacology       Date:  2014-09-28       Impact factor: 5.250

4.  Altered Cav1.2 function in the Timothy syndrome mouse model produces ascending serotonergic abnormalities.

Authors:  Daniel G Ehlinger; Kathryn G Commons
Journal:  Eur J Neurosci       Date:  2017-10-05       Impact factor: 3.386

5.  Projections and interconnections of genetically defined serotonin neurons in mice.

Authors:  Sun Jung Bang; Patricia Jensen; Susan M Dymecki; Kathryn G Commons
Journal:  Eur J Neurosci       Date:  2011-12-13       Impact factor: 3.386

6.  Evidence for intact 5-HT1A receptor-mediated feedback inhibition following sustained antidepressant treatment in a rat model of depression.

Authors:  Jessica A Babb; Sofia E Linnros; Kathryn G Commons
Journal:  Neuropharmacology       Date:  2018-08-28       Impact factor: 5.250

Review 7.  Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders.

Authors:  Matthew W Hale; Anantha Shekhar; Christopher A Lowry
Journal:  Cell Mol Neurobiol       Date:  2012-04-07       Impact factor: 5.046

Review 8.  Ascending serotonin neuron diversity under two umbrellas.

Authors:  Kathryn G Commons
Journal:  Brain Struct Funct       Date:  2016-01-06       Impact factor: 3.270

Review 9.  Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior.

Authors:  Stefanie C Altieri; Alvaro L Garcia-Garcia; E David Leonardo; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2012-12-20       Impact factor: 4.418

10.  Perinatal Nicotine Reduces Chemosensitivity of Medullary 5-HT Neurons after Maturation in Culture.

Authors:  Joanne Avraam; Yuanming Wu; George Bradley Richerson
Journal:  Neuroscience       Date:  2020-08-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.